H-Glu-OMe

H-Glu-OMe (methyl L-glutamate) is an amino acid methyl ester featuring the L-glutamate backbone with a side-chain carboxylate functionality masked as an ester and an α-amino group protected as a free N-terminus in the H form. The molecule presents a stereogenic center at the α-carbon, enabling stereochemically defined glutamate-derived transformations, while the ester group alters polarity and coupling behavior relative to the corresponding free acid. The combination of an amino functionality and an ester-activated carboxylate supports controlled peptide coupling after conversion to an appropriate activated acid derivative or after orthogonal protection strategies. H-Glu-OMe therefore functions as a chiral glutamate ester intermediate for amino acid derivatization, protected amino acid synthesis, and downstream peptide-building-block preparation.

1. Peptide Coupling Building Blocks

H-Glu-OMe (methyl L-glutamate) is used in peptide synthesis planning where glutamate residues must be introduced with defined stereochemistry and a side-chain carboxylate that can be carried through coupling steps. The α-amino group and the esterified carboxylate provide a handle for conversion into activated coupling partners, while the L-configuration supports stereochemically consistent incorporation into peptide chains. Ester-to-acid and acid-to-activated-derivative interconversions can be applied to align the side-chain functionality with standard peptide coupling chemistries. The resulting glutamate-containing intermediates can be advanced toward protected glutamate building blocks and peptide analogs used in structure-activity relationship studies and peptide material research.

2. Protected Glutamate Synthesis

H-Glu-OMe (methyl L-glutamate) serves as a practical chiral starting material for preparing N-protected glutamate derivatives and orthogonally protected side-chain carboxylates. The methyl ester can be selectively hydrolyzed to generate a glutamic acid acid functionality when an unmasked side chain is required for further protection or for orthogonal deprotection schemes. The α-amino functionality enables installation of common peptide-compatible protecting groups, supporting controlled N-terminal chemistry during multi-step synthesis. Downstream, protected glutamate building blocks derived from H-Glu-OMe can be utilized to construct peptides, peptidomimetics, and glutamate-based synthetic fragments with predictable functional-group compatibility.

3. Chemical Biology Labeling

H-Glu-OMe (methyl L-glutamate) can be applied to chemical biology workflows that require glutamate-based scaffolds bearing reactive handles for conjugation or affinity-tagging. The ester and amino functionalities can be transformed into electrophilic or activated intermediates that participate in amide bond formation, carbamate formation, or other nucleophile-driven coupling strategies under controlled conditions. The L-glutamate stereochemistry is relevant for maintaining recognition patterns in glutamate-derived probes and for generating stereodefined conjugates used in biochemical assay development. Glutamate ester intermediates prepared from H-Glu-OMe can also be routed into labeled peptides and side-chain-modified analogs for mapping molecular interactions.

4. Process Chemistry Intermediate

H-Glu-OMe (methyl L-glutamate) is suitable for process chemistry intermediate preparation where amino acid esters are used to manage solubility, reactivity, and purification characteristics during scale-up. The methyl ester form allows controlled downstream conversion to carboxylic acid derivatives for activation and coupling, while the L-chiral center supports stereochemical integrity across manufacturing steps. The presence of an amino group enables planned protection/deprotection sequences that align with peptide-grade intermediate specifications and multi-step batch synthesis. Glutamate ester-based routes can feed into fine chemical synthesis programs that require consistent chiral amino acid derivatives for peptide building blocks and specialty reagents.

5. Pharmaceutical Intermediate Routes

H-Glu-OMe (methyl L-glutamate) can be incorporated into pharmaceutical intermediate supply chains that rely on chiral glutamate fragments for peptidic and peptidomimetic scaffolds. The amino acid ester structure supports conversion into activated carboxylic acid forms and N-protected glutamate derivatives used in iterative fragment assembly and scaffold diversification. Side-chain carboxylate functionality, once unmasked or reprotected, can be positioned for subsequent coupling to heteroatom-containing motifs or for incorporation into constrained peptide-like structures. The stereodefined glutamate intermediate character of H-Glu-OMe supports downstream synthesis of functionalized amino acid derivatives used in medicinal chemistry and applied research chemistry programs.

1. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

2. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells